The European Commission (EC) has awarded Antares Vision, provider of serialisation-based track and trace solutions for the pharma industry, a grant for the development of new technology for the inspection of lyophilised injectables.
This grant will be used to fund the company’s Lyo-Check Project, which is aimed at the development of a fully automated industrial machine for 100% inspection of lyophiles. The machine will be based on vision architecture – a dedicated software and optical layout combined with ancillary technology — as well as Headspace Gas Analysis (HGSA) for testing product sterility via container integrity inspection.
“This is uplifting recognition of the complex systems our Inspection Machines Division has launched in the last few years,” said Davide Sacchetti, business development manager, Machines Division for Antares Vision. “Over this time period, several multinationals manufacturing high volume parenteral products have chosen Antares solutions for combined vision inspection and leak detection due to our innovative vision architecture, which makes it possible to inspect through the types of matt plastic typical in the blow-fill-seal process.”
“Although Antares Vision is widely known for being the world leader in serialisation solutions for the pharma industry,” added Adriano Fusco, strategy and development director for Antares Vision, “this EU Horizon 2020 SME Grant directly acknowledges the impressive talents of our research and development team in the visual inspection niche.”